Oregon Public Employees Retirement Fund’s Pacira BioSciences PCRX Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$229K	Sell	9,011 -400	-4%	-$9.46K	﹤0.01%	1433
2026 Q1	$213K	Sell	9,411 -458	-5%	-$10.2K	﹤0.01%	1410
2025 Q4	$255K	Sell	9,869 -300	-3%	-$7.13K	﹤0.01%	1371
2025 Q3	$262K	Sell	10,169 -400	-4%	-$9.82K	﹤0.01%	1343
2025 Q2	$253K	Sell	10,569 -40	-0.4%	-$1.01K	﹤0.01%	1337
2025 Q1	$264K	Sell	10,609 -300	-3%	-$7.18K	0.01%	1318
2024 Q4	$206K	Hold	10,909	–	–	﹤0.01%	1403
2024 Q3	$164K	Sell	10,909 -400	-4%	-$6.84K	﹤0.01%	1453
2024 Q2	$324K	Sell	11,309 -1,100	-9%	-$31.3K	0.01%	1274
2024 Q1	$363K	Sell	12,409 -1,200	-9%	-$36.9K	0.01%	1265
2023 Q4	$459K	Sell	13,609 -200	-1%	-$5.85K	0.01%	1248
2023 Q3	$424K	Sell	13,809 -500	-3%	-$18K	0.01%	1333
2023 Q2	$573K	Sell	14,309 -400	-3%	-$16.5K	0.01%	1258
2023 Q1	$600K	Sell	14,709 -540	-4%	-$21.5K	0.01%	1223
2022 Q4	$589K	Buy	15,249 +29	+0.2%	+$1.41K	0.01%	1233
2022 Q3	$810K	Buy	15,220 +300	+2%	+$16.7K	0.01%	1040
2022 Q2	$870K	Sell	14,920 -1,993	-12%	-$131K	0.01%	880
2022 Q1	$1.29M	Hold	16,913	–	–	0.01%	958
2021 Q4	$1.02M	Sell	16,913 -800	-5%	-$44.1K	0.01%	1002
2021 Q3	$992K	Sell	17,713 -100	-0.6%	-$5.76K	0.01%	996
2021 Q2	$1.08M	Hold	17,813	–	–	0.01%	978
2021 Q1	$1.25M	Buy	17,813 +572	+3%	+$40.9K	0.01%	880
2020 Q4	$1.03M	Sell	17,241 -59	-0.3%	-$3.46K	0.01%	890
2020 Q3	$1.04M	Buy	17,300 +300	+2%	+$17.4K	0.02%	752
2020 Q2	$892K	Hold	17,000	–	–	0.01%	846
2020 Q1	$570K	Hold	17,000	–	–	0.01%	961
2019 Q4	$770K	Buy	+17,000	New	+$722K	0.01%	1023

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Oregon Public Employees Retirement Fund's PCRX Position: Q2 2026 in Review

Oregon Public Employees Retirement Fund reduced its Pacira BioSciences (PCRX) stake by 4.3% in Q2 2026, selling an estimated $9.46K and leaving 9,011 shares worth $229K. The position accounts for ﹤0.01% of the portfolio, ranked #1433.

Oregon Public Employees Retirement Fund first reported a position in PCRX in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.29M in Q1 2022. 253 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

Oregon Public Employees Retirement Fund held 9,011 shares of Pacira BioSciences worth $229K as of Q2 2026.
Oregon Public Employees Retirement Fund sold 400 Pacira BioSciences shares in Q2 2026, an estimated $9.46K.
Pacira BioSciences made up ﹤0.01% of Oregon Public Employees Retirement Fund's portfolio in Q2 2026, its #1433 holding.
Oregon Public Employees Retirement Fund first reported a position in Pacira BioSciences in Q4 2019 and has held it in 27 quarters since.
Oregon Public Employees Retirement Fund's Pacira BioSciences position peaked at $1.29M in Q1 2022.
253 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.